Zacks Small Cap Research on MSN
COCP: Fast track designation for CDI-988 for norovirus infection treatment and prevention
By David Bautz, PhD NASDAQ: COCP READ THE FULL COCP RESEARCH REPORT Business Update Fast Track Designation for CDI-988 On April 2, 2026, Cocrystal Pharma, Inc. (NASDAQ: COCP) announced that the U.S.
Gold Project, Canada Latest assays include 70.8m @ 4.0% CuEq including 19.2m @ 7.5% CuEq ; These exceptional results will ...
Introduction Skin rash is the most common adverse effect in patients with cancer receiving epidermal growth factor receptor inhibitors (EGFRIs), which can impair quality of life and lead to treatment ...
Ontario man in custody for uttering death threats against PM Trudeau and other MPs Video Online, on GlobalNews.ca ...
Watch Grandson of one of Charles Manson’s victims has mixed feeling upon news of his death Video Online, on GlobalNews.ca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results